BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 10885905)

  • 1. Apoptosis induction and cell cycle perturbation in human hepatoma hep G2 cells by 10-hydroxycamptothecin.
    Zhang XW; Qing C; Xu B
    Anticancer Drugs; 1999 Jul; 10(6):569-76. PubMed ID: 10885905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of phosphorylation of histone H1 and H3 induced by 10-hydroxycamptothecin, DNA topoisomerase I inhibitor, in murine ascites hepatoma cells.
    Ling YH; Xu B
    Zhongguo Yao Li Xue Bao; 1993 Nov; 14(6):546-50. PubMed ID: 8010056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential regulation of P53, c-Myc, Bcl-2, Bax and AFP protein expression, and caspase activity during 10-hydroxycamptothecin-induced apoptosis in Hep G2 cells.
    Zhang XW; Xu B
    Anticancer Drugs; 2000 Oct; 11(9):747-56. PubMed ID: 11129738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation-inducing action of 10-hydroxycamptothecin on human hepatoma Hep G2 cells.
    Zhang XW; Jiang JF; Xu B
    Acta Pharmacol Sin; 2000 Apr; 21(4):364-8. PubMed ID: 11324469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inhibition of hydroxycamptothecin on laryngeal squamous carcinoma cell line].
    Chai LP; Su ZZ; Xian ZX
    Ai Zheng; 2003 Apr; 22(4):372-5. PubMed ID: 12703991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 10-Hydroxycamptothecin induces apoptosis in human neuroblastoma SMS-KCNR cells through p53, cytochrome c and caspase 3 pathways.
    Yuan ZF; Tang YM; Xu XJ; Li SS; Zhang JY
    Neoplasma; 2016; 63(1):72-9. PubMed ID: 26639236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of baicalein and 10-hydroxy camptothecin exerts remarkable synergetic anti-cancer effects.
    Tang Q; Ji F; Sun W; Wang J; Guo J; Guo L; Li Y; Bao Y
    Phytomedicine; 2016 Dec; 23(14):1778-1786. PubMed ID: 27912880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antitumor effects of ring-closed and ring-opened hydroxycamptothecin on oral squamous carcinoma cell line Tca8113].
    Wang AX; Li S; Ding XQ; Chen Y; Chen D
    Ai Zheng; 2005 Aug; 24(8):970-4. PubMed ID: 16086875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticancer effects of low-dose 10-hydroxycamptothecin in human colon cancer.
    Ping YH; Lee HC; Lee JY; Wu PH; Ho LK; Chi CW; Lu MF; Wang JJ
    Oncol Rep; 2006 May; 15(5):1273-9. PubMed ID: 16596197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticancer properties of 10-hydroxycamptothecin in a murine melanoma pulmonary metastasis model in vitro and in vivo.
    Hu W; Zhang C; Fang Y; Lou C
    Toxicol In Vitro; 2011 Mar; 25(2):513-20. PubMed ID: 21093576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation of human hepatoma Hep G2 cells induced by 10-hydroxycamptothecin.
    Zhang X; Zhou Y; Xu B
    Chin Med J (Engl); 2000 Aug; 113(8):712-3. PubMed ID: 11776054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genistein sensitizes bladder cancer cells to HCPT treatment in vitro and in vivo via ATM/NF-κB/IKK pathway-induced apoptosis.
    Wang Y; Wang H; Zhang W; Shao C; Xu P; Shi CH; Shi JG; Li YM; Fu Q; Xue W; Lei YH; Gao JY; Wang JY; Gao XP; Li JQ; Yuan JL; Zhang YT
    PLoS One; 2013; 8(1):e50175. PubMed ID: 23365634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycyrrhetinic Acid and TAT Peptide Modified Dual-functional Liposomes for Treatment of Hepatocellular Cancer.
    Huang S; Ren D; Wu X; Li M; Yu X; Nie X; Wang Y; Wang Y
    Curr Top Med Chem; 2020; 20(27):2493-2505. PubMed ID: 32703132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of p21WAF1/CIP1 in human breast cancer cell lines MCF-7 and MDA-MB-468 undergoing apoptosis induced by natural product anticancer drugs 10-hydroxycamptothecin and camptothecin through p53-dependent and independent pathways.
    Liu W; Zhang R
    Int J Oncol; 1998 Apr; 12(4):793-804. PubMed ID: 9499438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxycamptothecin-induced apoptosis in hepatoma SMMC-7721 cells and the role of mitochondrial pathway.
    Fu YR; Yi ZJ; Yan YR; Qiu ZY
    Mitochondrion; 2006 Aug; 6(4):211-7. PubMed ID: 16926123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy of treatment with siRNA targeting Bcl-2 in combination with HCPT against transplanted H₂₂ hepatoma in mice].
    Hu HH; Song HX
    Zhonghua Zhong Liu Za Zhi; 2013 Dec; 35(12):892-6. PubMed ID: 24506957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid nanoparticles loaded with 10-hydroxycamptothecin-phospholipid complex developed for the treatment of hepatoma in clinical application.
    Wei W; Shi SJ; Liu J; Sun X; Ren K; Zhao D; Zhang XN; Zhang ZR; Gong T
    J Drug Target; 2010 Aug; 18(7):557-66. PubMed ID: 20131981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of apoptosis in human cancer cells by TZT-1027, an antimicrotubule agent.
    Watanabe J; Natsume T; Fujio N; Miyasaka K; Kobayashi M
    Apoptosis; 2000 Oct; 5(4):345-53. PubMed ID: 11227216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-tumor effect of (S)-10-hydroxycamptothecin on mouse hepatoma BW7756 and its possible mode of action.
    Tsou KC; Xu B; Miller EE; Lo KW
    Anticancer Res; 1981; 1(2):115-9. PubMed ID: 7347154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of hydroxycamptothecin in the activity of RNA and DNA polymerases prepared from murine hepatoma cells.
    Xu B; Ling YH
    Am J Chin Med; 1985; 13(1-4):23-31. PubMed ID: 4025212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.